TipRanks
Advertisement
Advertisement

DE:3D0A Stock Latest News

Telo Genomics’ Blood-Based TELO-MRD Shows Strong MRD Detection in Multiple Myeloma Comparisons
Company AnnouncementsTelo Genomics’ Blood-Based TELO-MRD Shows Strong MRD Detection in Multiple Myeloma Comparisons
4d ago
Telo Genomics’ Blood-Based Myeloma Assay Outperforms Bone-Marrow MRD Test in Study
PremiumCompany Announcements
Telo Genomics’ Blood-Based Myeloma Assay Outperforms Bone-Marrow MRD Test in Study
17d ago
PremiumCompany Announcements
Telo Genomics Advances Blood-Based MRD Testing in Myeloma with New Study and CAP Accreditation
6M ago
PremiumCompany Announcements
Telo Genomics Installs New CEO and Chairman as It Prepares for Pivotal Oncology Milestones
6M ago
PremiumCompany Announcements
Telo Genomics Raises $1.39 Million in Final Convertible Debenture Tranche
7M ago
PremiumCompany AnnouncementsTelo Genomics Upsizes Convertible Debenture Financing to $1.6 Million
7M ago
Premium
Company Announcements
Telo Genomics Raises $840,000 in First Tranche of Convertible Debenture Financing
8M ago
Telo Genomics Strengthens Finance Team With Appointment of Veteran CFO John Price
Premium
Company Announcements
Telo Genomics Strengthens Finance Team With Appointment of Veteran CFO John Price
8M ago
Telo Genomics Seeks Up to $1.2 Million via Convertible Debenture Financing
PremiumCompany Announcements
Telo Genomics Seeks Up to $1.2 Million via Convertible Debenture Financing
9M ago
Telo Genomics Expands Multiple Myeloma MRD Validation with University of Athens Study
PremiumCompany Announcements
Telo Genomics Expands Multiple Myeloma MRD Validation with University of Athens Study
10M ago
Telo Genomics Unveils Innovative Myeloma Testing at ASH Meeting
PremiumCompany Announcements
Telo Genomics Unveils Innovative Myeloma Testing at ASH Meeting
10M ago
Telo Genomics Unveils Advanced MRD Technology at Myeloma Summit
PremiumCompany Announcements
Telo Genomics Unveils Advanced MRD Technology at Myeloma Summit
11M ago
Telo Genomics’ MRD Technology Gains Recognition at ASH 2025
PremiumCompany AnnouncementsTelo Genomics’ MRD Technology Gains Recognition at ASH 2025
12M ago
Telo Genomics Expands with New Toronto Facility and Board Update
Premium
Company Announcements
Telo Genomics Expands with New Toronto Facility and Board Update
1y ago
Telo Genomics Unveils Innovative MRD Methodology at Myeloma Society Meeting
Premium
Company Announcements
Telo Genomics Unveils Innovative MRD Methodology at Myeloma Society Meeting
1y ago
Telo Genomics Engages Hayden IR for Investor Relations Enhancement
PremiumCompany Announcements
Telo Genomics Engages Hayden IR for Investor Relations Enhancement
1y ago
Telo Genomics to Showcase New Strategy at OTCQB Virtual Investor Conference
PremiumCompany Announcements
Telo Genomics to Showcase New Strategy at OTCQB Virtual Investor Conference
1y ago
Telo Genomics’ MRD Abstract Accepted for Presentation at International Myeloma Society Meeting
PremiumCompany Announcements
Telo Genomics’ MRD Abstract Accepted for Presentation at International Myeloma Society Meeting
1y ago
Telo Genomics to Contest Former President’s Lawsuit
PremiumCompany Announcements
Telo Genomics to Contest Former President’s Lawsuit
1y ago
Telo Genomics Launches Clinical Trial for Enhanced Multiple Myeloma Assessment
PremiumCompany AnnouncementsTelo Genomics Launches Clinical Trial for Enhanced Multiple Myeloma Assessment
1y ago
Telo Genomics Advances IP Strategy with New Tier Status from IPON
Premium
Company Announcements
Telo Genomics Advances IP Strategy with New Tier Status from IPON
1y ago
Telo Genomics’ SMM Risk Prediction Abstract Accepted for EHA 2025 Congress
Premium
Company Announcements
Telo Genomics’ SMM Risk Prediction Abstract Accepted for EHA 2025 Congress
1y ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >